▶ 調査レポート

アメリカのイソキサゾリン市場2020年ー2030年:製品タイプ別(フルララネル、アフォキソラネル、サロラネル、ロチラネル)、ペット種類別

• 英文タイトル:Isoxazoline Market (Product Type: Fluralaner, Afoxolaner, Sarolaner, and Lotilaner; and Pet Type: Dog and Cat) – U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Transparency Market Researchが調査・発行した産業分析レポートです。アメリカのイソキサゾリン市場2020年ー2030年:製品タイプ別(フルララネル、アフォキソラネル、サロラネル、ロチラネル)、ペット種類別 / Isoxazoline Market (Product Type: Fluralaner, Afoxolaner, Sarolaner, and Lotilaner; and Pet Type: Dog and Cat) – U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 / MRC2103G005資料のイメージです。• レポートコード:MRC2103G005
• 出版社/出版日:Transparency Market Research / 2020年12月21日
• レポート形態:英文、PDF、48ページ
• 納品方法:Eメール
• 産業分類:化学
• 販売価格(消費税別)
  Single User¥747,555 (USD5,795)▷ お問い合わせ
  Site Licence¥1,134,555 (USD8,795)▷ お問い合わせ
  Enterprisewide Licence¥1,521,555 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査資料では、アメリカのイソキサゾリン市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、製品タイプ別分析、ペット種類別分析、競争状況などの構成でまとめております。

U.S. Isoxazoline Market – Scope of the Report
The latest study collated and published by Transparency Market Research (TMR) analyzes the historical and present-day scenario of the U.S. Isoxazoline market to gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating a landscape for the growth of the U.S. Isoxazoline market. The study also identifies growth avenues for market stakeholders. The report provides insightful information about how the U.S. Isoxazoline market is likely to expand during the forecast period of 2020 to 2030.

The report offers intricate dynamics about different aspects of the U.S. Isoxazoline market that can aid companies operating in the market in making strategic business decisions. TMR’s study also elaborates on significant changes that are anticipated to configure growth of the pet care industry with respect to the U.S. Isoxazoline market during the forecast period. It also includes a key indicator assessment that highlights growth prospects for the U.S. Isoxazoline market and estimates statistics related to growth of the market in terms of volume (Thousand Units) and value (US$ Mn).

This study covers a detailed segmentation of the U.S. Isoxazoline market, along with key information and competition landscape. The report mentions company profiles of major players operating in the U.S. Isoxazoline market, wherein various market developments and growth strategies practiced and implemented by leading players have been presented in detail.

Key Questions Answered in TMR’s Report on U.S. Isoxazoline Market

The report provides detailed information about the U.S. Isoxazoline market on the basis of comprehensive research on various factors that are playing a key role in accelerating the growth of the market. Information mentioned in the report answers path-breaking questions for companies that are currently operating in the market and are looking for innovative methods to create a unique benchmark in the U.S. Isoxazoline market, which would help them design successful strategies and make target-driven decisions.

Which product type segment of the U.S. Isoxazoline market would emerge as a leading revenue generator during the forecast period?
What would be the Y-o-Y growth rate of the U.S. Isoxazoline market between 2020 and 2030?
What are winning imperatives of leading players operating in the U.S. Isoxazoline market?
Research Methodology – U.S. Isoxazoline Market

The research methodology adopted by analysts for compiling the report on the U.S. Isoxazoline market is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts of the U.S. Isoxazoline market.

For primary research, analysts have interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the U.S. Isoxazoline market.

For secondary research, analysts have scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the U.S. Isoxazoline market.

レポート目次

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary: U.S. Isoxazoline Market
3.1. Market Value, Indicative (US$ Mn)
3.2. Top Three Trends
4. Market Overview
4.1. Product Overview
4.2. Key Market Developments
4.3. Market Indicators
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.1.1.1. Drivers
5.1.1.2. Restraints
5.1.1.3. Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of Substitutes
5.2.2. Bargaining Power of Buyers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of New Entrants
5.2.5. Degree of Competition
5.3. Value Chain Analysis
6. U.S. Isoxazoline Market Volume (Thousand Units) and Value (US$ Mn) Analysis, by Product Type
6.1. Key Findings and Introduction
6.2. U.S. Isoxazoline Market Volume (Thousand Units) and Value (US$ Mn) Forecast, by Product Type, 2017–2030
6.2.1. Fluralaner
6.2.2. Afoxolaner
6.2.3. Sarolaner
6.2.4. Lotilaner
6.3. U.S. Isoxazoline Market Volume (Thousand Units) and Value (US$ Mn) Forecast, by Pet Type, 2017–2030
6.3.1. Dog
6.3.2. Cat
7. Competition Landscape
7.1. Company Profiles
7.1.1. Merck Animal Health Inc.
7.1.1.1. Company Description
7.1.1.2. Business Overview
7.1.1.3. Production Capacity
7.1.1.4. Siam Steel Galvanizing Factories List
7.1.1.5. Product Description
7.1.2. Boehringer Ingelheim International GmbH
7.1.2.1. Company Description
7.1.2.2. Business Overview
7.1.2.3. Production Capacity
7.1.2.4. Product Description
7.1.3. Zoetis Inc.
7.1.3.1. Company Description
7.1.3.2. Business Overview
7.1.3.3. Production Capacity
7.1.3.4. Product Description
7.1.4. Elanco Animal Health Incorporated
7.1.4.1. Company Description
7.1.4.2. Business Overview
7.1.4.3. Product Description
7.1.4.4. Financial Overview
8. Assumptions and Research Methodology
8.1. Report Assumptions
8.2. Secondary Sources and Acronyms Used
8.3. Research Methodology

List of Tables

Table 01: Number of U.S. Households That Own Pet, by Type of Animal (Million)

Table 02: U.S. Isoxazoline Market Value (US$ Mn) Forecast, by Product Type, 2019–2030

Table 03: U.S. Isoxazoline Market Volume (Thousand Units) Forecast, by Product Type, 2017–2030

Table 04: U.S. Isoxazoline Market Value (US$ Mn) Forecast, by Product Type, 2017–2030

Table 05: U.S. Isoxazoline Market Volume (Thousand Units) Forecast, by Pet Type, 2017–2030

Table 06: U.S. Isoxazoline Market Value (US$ Mn) Forecast, by Pet Type, 2017–2030